Microsoft's spreadsheet program can do way more than you might imagine. These are the hacks and tricks you need to know.

Learn the difference between Excel COUNT and COUNTA, plus TEXTBEFORE and TEXTAFTER tricks, so you clean text and totals with ...

ABSTRACT: This study examined the relationship between the Monetary Policy Rate (MPR) and inflation across five continents from 2014 to 2023 using both Frequentist and Bayesian Linear Mixed Models ...

Some of the citations that underpin the science in the White House’s sweeping “MAHA Report” appear to have been generated using artificial intelligence, resulting in numerous garbled scientific ...

Ramanujan’s elegant formulas for calculating pi, developed more than a century ago, have unexpectedly resurfaced at the heart of modern physics. Researchers at IISc discovered that the same ...

Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...

A schematic illustration of how GigTIME can take a hematoxylin and eosin (H&E) pathology slide and use AI to virtually identify a suite of proteins that would otherwise require multiplex ...

Bitcoin enters December with a historically mixed track record, often characterized by sharp outliers and erratic flows. Analyst Daan Crypto notes that recent years have been relatively muted, but the ...

President Donald Trump posted a series of anti-immigration messages on Thanksgiving, one of which included a slur. In a Truth Social post, Trump used the "r-word" to describe Minnesota Gov. Tim Walz.

Durham leaders have approved a rezoning request that will allow Research Triangle Park to become more of a destination hub. Durham County Board of Commissioners voted unanimously on Monday to amend ...

Shares of Agios Pharmaceuticals AGIO tanked about 51% on Wednesday after it reported mixed top-line results from the phase III RISE UP study, which evaluated orally administered Pyrukynd (mitapivat) ...

Nov 19 (Reuters) - Agios Pharmaceuticals (AGIO.O), opens new tab said on Wednesday its sickle cell disease drug met one of its two main goals in a late-stage study of patients aged 16 and older but ...